Afya (NASDAQ:AFYA) Price Target Lowered to $21.00 at JPMorgan Chase & Co.

Afya (NASDAQ:AFYA) had its price target dropped by equities researchers at JPMorgan Chase & Co. from $21.50 to $21.00 in a research report issued on Monday,Benzinga reports. The brokerage presently has a “neutral” rating on the stock. JPMorgan Chase & Co.‘s price target points to a potential upside of 49.05% from the company’s previous close.

A number of other research analysts have also recently weighed in on the company. Wall Street Zen cut Afya from a “strong-buy” rating to a “buy” rating in a research report on Saturday, May 2nd. Bank of America restated a “neutral” rating on shares of Afya in a research note on Thursday, June 11th. Zacks Research downgraded shares of Afya from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, May 6th. Finally, Weiss Ratings reissued a “hold (c)” rating on shares of Afya in a report on Monday, April 20th. One equities research analyst has rated the stock with a Buy rating and seven have given a Hold rating to the company’s stock. According to data from MarketBeat, the company has an average rating of “Hold” and an average price target of $17.10.

Afya Stock Performance

NASDAQ AFYA opened at $14.09 on Monday. Afya has a 12-month low of $13.00 and a 12-month high of $18.16. The company has a current ratio of 1.78, a quick ratio of 1.78 and a debt-to-equity ratio of 0.42. The business’s 50 day moving average is $14.43 and its two-hundred day moving average is $14.54. The stock has a market capitalization of $1.32 billion, a price-to-earnings ratio of 9.23, a PEG ratio of 1.44 and a beta of 0.34.

Insiders Place Their Bets

In related news, insider Santos Welder Ferreira sold 3,325 shares of Afya stock in a transaction dated Friday, April 17th. The stock was sold at an average price of $15.90, for a total transaction of $52,867.50. Following the transaction, the insider directly owned 35,000 shares of the company’s stock, valued at $556,500. The trade was a 8.68% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, VP De Sousa Anibal Jose Grifo sold 14,000 shares of the stock in a transaction on Monday, April 13th. The shares were sold at an average price of $15.41, for a total value of $215,740.00. Following the sale, the vice president owned 31,000 shares of the company’s stock, valued at $477,710. This trade represents a 31.11% decrease in their position. The disclosure for this sale is available in the SEC filing. Over the last ninety days, insiders sold 123,547 shares of company stock valued at $1,854,920.

Institutional Inflows and Outflows

Institutional investors have recently made changes to their positions in the business. Doma Perpetual Capital Management LLC raised its holdings in Afya by 50.6% in the 3rd quarter. Doma Perpetual Capital Management LLC now owns 891,639 shares of the company’s stock valued at $13,910,000 after buying an additional 299,419 shares during the last quarter. SPX Gestao de Recursos Ltda acquired a new stake in shares of Afya during the third quarter worth $2,895,000. Swedbank AB raised its position in shares of Afya by 170.3% in the 4th quarter. Swedbank AB now owns 189,200 shares of the company’s stock worth $2,916,000 after acquiring an additional 119,200 shares in the last quarter. Jump Financial LLC acquired a new stake in shares of Afya during the 2nd quarter worth approximately $731,000. Finally, Qube Research & Technologies Ltd bought a new stake in Afya in the third quarter valued at $610,000. 88.02% of the stock is owned by institutional investors.

About Afya

Afya Ltd. operates as a leading provider of medical education and training services in Brazil. The company offers a comprehensive suite of educational programs that span undergraduate medical degrees, residency exam preparation, continuing medical education (CME) and digital learning platforms. Through a network of partner institutions and its own campus operations, Afya supports students at every stage of the medical training continuum, from enrollment in medical schools to ongoing professional development for practicing physicians.

At the core of Afya’s offerings is its undergraduate medical program, delivered through a combination of in-person courses at affiliated campuses and fully digital curricula.